12:00 AM
Oct 04, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

FK463: Phase II

Fujisawa reported data from 79 patients in which a 1-hour infusion of 50 mg, 25 mg and 12.5 mg FK463 for at...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >